FEBRUARY 18, 2019

The Year in Viral Hepatitis: Part 1

img-button
Saikiran Kilaru, MD
Fellow
Division of Gastroenterology and Hepatology
Department of Medicine
NYU Langone Health
New York City
img-button
Ira Jacobson, MD
Director of Hepatology
NYU Langone Health
New York City



Although 2018 saw no major drug approvals or dramatic breakthroughs for viral hepatitis, researchers continued to make progress against these infections. We asked Drs. Ira Jacobson and Saikiran Kilaru for an overview of the most important findings reported last year.

As with the hepatitis C virus (HCV), the